One Biomed

Provider of molecular diagnostic services

placeSingapore, Singapore, Singapore calendar_todayFounded 2015 groups10 employees language onebiomed.com

Registered entities

Innovation

4 patent families (1 granted) — focus: Chemistry & metallurgy, Operations & transport, Human necessities; filing pace slowing. Cited 52 times.

YearFilings
20192
20202
20211
20221
20231
20241

Investor mix

12 investors on record; lead investors include BioPath Ventures, Arch Venture Partners, JW Bioscience.

Investor typeCountShare
Venture capital217%
Other / undisclosed1083%
Coming soon